The comparison of Temple with Coronil is significant because Coronil became a prominent example of a health product facing criticism over claims that went beyond its approved use. Deepinder Goyal's Rs 85,000 Temple wearable has sparked a war of words with doctors over its brain-monitoring claims, scientific evidence and validation.